Diana Buist
#175,289
Most Influential Person Now
American epidemiologist
Diana Buist's AcademicInfluence.com Rankings
Diana Buistmedical Degrees
Medical
#3640
World Rank
#4129
Historical Rank
Epidemiology
#753
World Rank
#785
Historical Rank
Download Badge
Medical
Diana Buist's Degrees
- PhD Epidemiology University of Washington
- Masters Epidemiology University of Washington
- Bachelors Biology University of California, San Diego
Similar Degrees You Can Earn
Why Is Diana Buist Influential?
(Suggest an Edit or Addition)According to Wikipedia, Diana S.M. Buist is an American epidemiologist. She is a senior investigator and director of research and strategic partnerships at Kaiser Permanente Washington Research Institute. Early life and education Buist was born to the United Kingdom born physician-researchers Sonia and Neil Buist. She earned her PhD in epidemiology from the University of Washington and her MPH in the same subject from Yale University.
Diana Buist's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection. (2015) (417)
- Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women (2000) (408)
- National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. (2017) (362)
- Factors contributing to mammography failure in women aged 40-49 years. (2004) (312)
- Risk Factors for Breast Cancer for Women Aged 40 to 49 Years (2012) (274)
- Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. (2003) (261)
- Use of Alternative Therapies for Menopause Symptoms: Results of a Population‐Based Survey (2002) (251)
- Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. (2007) (234)
- Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. (2010) (209)
- Hormone Therapy Prescribing Patterns in the United States (2004) (205)
- Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49 (2004) (179)
- Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms (2020) (168)
- Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. (2007) (157)
- Association between Mammographic Breast Density and Breast Cancer Tumor Characteristics (2005) (140)
- Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. (2011) (138)
- Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. (2003) (130)
- Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density (2018) (128)
- Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. (2014) (123)
- Risk Factors for Breast Cancer for Women Aged 40 to 49 Years A Systematic Review and Meta-analysis (2012) (119)
- Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. (2001) (108)
- Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates. (2010) (107)
- Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. (2014) (105)
- Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years (2012) (104)
- Biennial versus annual mammography and the risk of late-stage breast cancer. (2004) (103)
- Radiologist characteristics associated with interpretive performance of diagnostic mammography. (2007) (103)
- Pathologic findings from the Breast Cancer Surveillance Consortium (2006) (97)
- Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age. (2014) (96)
- Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. (2012) (94)
- Influence of annual interpretive volume on screening mammography performance in the United States. (2011) (91)
- Statin Use and Breast Cancer Risk in a Large Population-Based Setting (2007) (90)
- Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer (2014) (87)
- Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. (2012) (85)
- Reproductive history and risk of three breast cancer subtypes defined by three biomarkers (2011) (84)
- Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population (2013) (83)
- Obesity, mammography use and accuracy, and advanced breast cancer risk. (2008) (82)
- National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium. (2017) (82)
- The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. (2005) (82)
- Circulating serum xenoestrogens and mammographic breast density (2013) (82)
- A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer (2019) (75)
- Performance of first mammography examination in women younger than 40 years. (2010) (73)
- Longitudinal Adherence With Fecal Occult Blood Test Screening in Community Practice (2010) (72)
- Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. (2015) (72)
- Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. (2012) (71)
- Will Machine Learning Tip the Balance in Breast Cancer Screening? (2017) (69)
- Risk factors for inflammatory breast cancer and other invasive breast cancers. (2013) (67)
- Evaluating Organized Breast Cancer Screening Implementation (2004) (65)
- Statin use and prostate cancer risk in a large population-based setting (2008) (65)
- Geographic access to breast imaging for US women. (2014) (65)
- Artificial intelligence for breast cancer screening: Opportunity or hype? (2017) (63)
- When radiologists perform best: the learning curve in screening mammogram interpretation. (2009) (62)
- Breast cancer recurrence risk in relation to antidepressant use after diagnosis (2008) (61)
- Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT. (2014) (59)
- Bone mineral density and breast cancer risk in postmenopausal women. (2001) (59)
- Risk factors for mortality in middle-aged women. (2006) (59)
- Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. (2002) (56)
- Performance Benchmarks for Screening Breast MR Imaging in Community Practice. (2017) (53)
- Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort. (2013) (51)
- Gastric and duodenal safety of daily alendronate. (2002) (51)
- Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk (2011) (51)
- Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. (2005) (48)
- Patient and oncologist discussions about cancer care costs (2014) (48)
- Statin use and female reproductive organ cancer risk in a large population-based setting (2009) (44)
- The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography (2011) (44)
- Are long-term hormone replacement therapy users different from short-term and never users? (1999) (43)
- Automated inter-rater reliability assessment and electronic data collection in a multi-center breast cancer study (2007) (42)
- Reported mammographic density: film-screen versus digital acquisition. (2013) (42)
- Cost-effectiveness studies of HPV self-sampling: A systematic review. (2020) (41)
- Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use. (2010) (40)
- Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women (2011) (40)
- Mammographic Breast Density, Dense Area, and Breast Area Differences by Phase in the Menstrual Cycle (2006) (39)
- Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors (2014) (39)
- Bone Mineral Density and Endogenous Hormones and Risk of Breast Cancer in Postmenopausal Women (United States) (2001) (39)
- Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. (2009) (39)
- Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk. (2019) (38)
- Taking action on overuse: Creating the culture for change. (2017) (38)
- Emerging Trends in Family History of Breast Cancer and Associated Risk (2017) (37)
- Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging. (2019) (37)
- Frequent Antibiotic Use and Second Breast Cancer Events (2013) (35)
- Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: A report from the Breast Cancer Surveillance Consortium (2015) (34)
- Primary Care Clinicians' Perspectives on Reducing Low-Value Care in an Integrated Delivery System. (2015) (33)
- Radiologist agreement for mammographic recall by case difficulty and finding type. (2012) (33)
- Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort (2018) (32)
- Circulating Sex Hormones and Mammographic Breast Density among Postmenopausal Women (2011) (32)
- Improving the concordance of mammography assessment and management recommendations. (2006) (32)
- Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. (2019) (31)
- Five-year risk of interval-invasive second breast cancer. (2015) (31)
- Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population (2017) (31)
- Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B∼FIT Cohort (2016) (31)
- Validation of natural language processing to extract breast cancer pathology procedures and results (2015) (31)
- Using natural language processing to extract mammographic findings (2015) (30)
- Varying Levels of Family History of Breast Cancer in Relation to Mammographic Breast Density (United States) (2006) (30)
- Lesion and patient characteristics associated with malignancy after a probably benign finding on community practice mammography. (2008) (29)
- Average Household Exposure to Newspaper Coverage about the Harmful Effects of Hormone Therapy and Population-Based Declines in Hormone Therapy Use (2007) (28)
- Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment (2019) (28)
- Trends in BRCA Test Utilization in an Integrated Health System, 2005-2015. (2019) (27)
- Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history (2009) (27)
- Evaluation of Three Population-Based Strategies for Fracture Prevention: Results of the Osteoporosis Population-Based Risk Assessment (OPRA) Trial (2005) (26)
- Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms. (2004) (26)
- Effect of radiologists' diagnostic work-up volume on interpretive performance. (2014) (26)
- Mammographic interpretive volume and diagnostic mammogram interpretation performance in community practice. (2012) (26)
- Tamoxifen Initiation After Ductal Carcinoma In Situ (2016) (26)
- Evaluating Organized Breast Cancer Screening Implementation: The Prevention of Late-Stage Disease? (2004) (25)
- Breast cancer recurrence in relation to antidepressant use (2015) (25)
- What factors account for hormone replacement therapy prescribing frequency? (2001) (24)
- Screening mammography outcomes: risk of breast cancer and mortality by comorbidity score and age. (2019) (24)
- The influence of race/ethnicity and place of service on breast reconstruction for Medicare beneficiaries with mastectomy (2014) (24)
- Timeliness of follow-up after abnormal screening mammogram: variability of facilities. (2011) (23)
- Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial (2020) (23)
- Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer (2018) (22)
- The vitamin D pathway and mammographic breast density among postmenopausal women (2011) (21)
- Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States) (2006) (21)
- Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes (2016) (21)
- Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women (2020) (21)
- Digital Breast Tomosynthesis: Radiologist Learning Curve. (2019) (21)
- Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography. (2010) (20)
- Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care. (2007) (20)
- Accuracy of screening mammography varies by week of menstrual cycle. (2011) (20)
- Association between time spent interpreting, level of confidence, and accuracy of screening mammography. (2012) (20)
- Latina and Black/African American Women’s Perspectives on Cancer Screening and Cancer Screening Reminders (2017) (19)
- Influence of Primary Care Use on Population Delivery of Colorectal Cancer Screening (2009) (19)
- Estrogen Metabolites Are Not Associated with Colorectal Cancer Risk in Postmenopausal Women (2015) (18)
- An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events. (2017) (18)
- Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result. (2019) (18)
- Short-Term Hormone Therapy Suspension and Mammography Recall (2009) (17)
- Evaluation of decision rules to identify postmenopausal women for intervention related to osteoporosis. (2003) (17)
- Knowledge and Perception of Breast Density, Screening Mammography, and Supplemental Screening: in Search of “Informed” (2019) (17)
- An Assessment of the Quality of Mammography Care at Facilities Treating Medically Vulnerable Populations (2008) (17)
- The relationship between breast density and bone mineral density in postmenopausal women (2004) (16)
- Endocrine therapy initiation from 2001 to 2008 varies by age at breast cancer diagnosis and tumor size. (2012) (16)
- Advanced diagnostic breast cancer imaging: variation and patterns of care in Washington state. (2013) (16)
- Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium (2021) (16)
- Changes in newspaper coverage about hormone therapy with the release of new medical evidence (2006) (16)
- The impact of comorbidities on hormone use (2005) (16)
- An assessment of the likelihood, frequency, and content of verbal communication between radiologists and women receiving screening and diagnostic mammography. (2009) (15)
- Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response. (2005) (15)
- Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system. (2018) (15)
- Body Mass Index and Risk of Second Cancer among Women with Breast Cancer. (2021) (15)
- Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark. (2015) (15)
- Radiologists' attitudes and use of mammography audit reports. (2010) (14)
- Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic (2021) (14)
- Relationship between preoperative breast MRI and surgical treatment of non‐metastatic breast cancer (2017) (13)
- Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium. (2020) (13)
- Association of Breast Density With Breast Cancer Risk Among Women Aged 65 Years or Older by Age Group and Body Mass Index (2021) (13)
- Hormone therapy initiation after the Women's Health Initiative (2008) (13)
- Recommendations for strengthening the role of embedded researchers to accelerate implementation in health systems: Findings from a state-of-the-art (SOTA) conference workgroup. (2021) (13)
- Pathways to breast cancer screening artificial intelligence algorithm validation (2019) (12)
- Assessing Health Care Use and Cost Consequences of a New Screening Modality: The Case of Digital Mammography (2012) (12)
- Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer. (2022) (12)
- Response: Re: Performance of First Mammography Examination in Women Younger Than 40 Years (2010) (11)
- Association of the Intensity of Diagnostic Evaluation With Outcomes in Incidentally Detected Lung Nodules. (2021) (11)
- Establishing a gold standard for test sets: variation in interpretive agreement of expert mammographers. (2013) (11)
- Biopsy follow-up of prostate-specific antigen tests. (2012) (11)
- Factors associated with imaging and procedural events used to detect breast cancer after screening mammography. (2007) (11)
- Prioritizing comparative effectiveness research for cancer diagnostics using a regional stakeholder approach. (2012) (11)
- Breast cancer screening outreach effectiveness: Mammogram-specific reminders vs. comprehensive preventive services birthday letters. (2017) (11)
- The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative. (2005) (11)
- What level of risk tips the balance of benefits and harms to favor screening mammography starting at age 40 (2012) (10)
- Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer (2016) (10)
- Sleep problems after short-term hormone therapy suspension: secondary analysis of a randomized trial (2011) (10)
- Comparative effectiveness of two outreach strategies for cervical cancer screening. (2016) (10)
- Optimizing Implementation in Cancer Control (OPTICC): protocol for an implementation science center (2021) (9)
- Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography. (2018) (9)
- Understanding attitudes of older women toward hormone replacement therapy. (2001) (9)
- Recruiting and Training Leadership through Professional Societies: A Report from the American Society of Preventive Oncology Junior Members Interest Group (2006) (9)
- Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity (2021) (9)
- Women's responses to a mailed hormone replacement therapy workbook (2001) (9)
- Cancer Screening Reminders: Addressing the Spectrum of Patient Preferences. (2017) (9)
- Screening Mammography Use among Current, Former, and Never Hormone Therapy Users May Not Explain Recent Declines in Breast Cancer Incidence (2012) (9)
- Breast MRI in community practice: equipment and imaging techniques at facilities in the Breast Cancer Surveillance Consortium. (2010) (9)
- Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography (2013) (8)
- Electronic health risk assessment adoption in an integrated healthcare system. (2014) (8)
- Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study (2021) (8)
- Patient and Radiologist Characteristics Associated With Accuracy of Two Types of Diagnostic Mammograms. (2015) (8)
- Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer (2016) (8)
- Population-based strategy for improving informed decision making about hormone replacement therapy in managed care settings (1999) (8)
- Perceived barriers and recommendations concerning hormone replacement therapy counseling among primary care providers. (1999) (8)
- Conducting Cancer Control and Survivorship Research via Cooperative Groups: A Report from the American Society of Preventive Oncology (2011) (8)
- Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits (2019) (7)
- Independent External Validation of Artificial Intelligence Algorithms for Automated Interpretation of Screening Mammography: A Systematic Review. (2022) (7)
- Comparative effectiveness of mailed reminder letters on mammography screening compliance. (2012) (7)
- Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice. (2017) (7)
- Mammographic Breast Density and Serum Phytoestrogen Levels (2012) (6)
- Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors (2017) (6)
- Facility Variability in Examination Indication Among Women With Prior Breast Cancer: Implications and the Need for Standardization. (2020) (6)
- Short-term (1-2 mo) hormone therapy cessation before mammography (2009) (6)
- Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network (2019) (6)
- Antidepressant Medications and Change in Mammographic Density in Postmenopausal Women (2009) (5)
- Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016. (2021) (5)
- Predictors of Breast Density Change After Hormone Therapy Cessation: Results from a Randomized Trial (2011) (5)
- Radiologists' interpretive skills in screening vs. diagnostic mammography: are they related? (2016) (5)
- Effects of Digital Mammography Uptake on Downstream Breast-related Care Among Older Women (2012) (5)
- Fertility Drug Use and Mammographic Breast Density in a Mammography Screening Cohort of Premenopausal Women (2008) (5)
- Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer (2019) (4)
- Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study. (2022) (4)
- Physician Service Attribution Methods for Examining Provision of Low-Value Care (2017) (4)
- Preoperative MRI in breast cancer: effect of breast density on biopsy rate and yield (2021) (4)
- Relationship Between Use of Different Oral Contraceptive Formulations and Breast Cancer Risk Among Young Women (2012) (4)
- Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer (2016) (4)
- Investigation of mammographic breast density as a risk factor for ovarian cancer. (2014) (3)
- The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen‐Detected Breast Cancer in Older Women (2016) (3)
- 58 – Overview of Risk Factors for Cardiovascular Disease (2000) (3)
- Radiologist Agreement for Mammographic Recall by Case Difficulty and Finding Type. (2016) (3)
- Do breast cancer risk factors modify the association between hormone therapy and mammographie breast density (2006) (3)
- Is Breast MRI Better at Finding Second Breast Cancers than Mammograms Alone for Breast Cancer Survivors? (2019) (3)
- An Electronic Health Record–based Algorithm to Ascertain the Date of Second Breast Cancer Events (2017) (3)
- Primary care physician resource use changes associated with feedback reports. (2018) (2)
- External Validation of an Ensemble Model for Automated Mammography Interpretation by Artificial Intelligence (2022) (2)
- Factors associated with non-compliance with hormone therapy cessation before screening mammography (2011) (2)
- Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging. (2017) (2)
- Time scale in follow-up studies: considering disease prognosis. (2013) (2)
- Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis (2019) (2)
- P-12. The Use of Alternative and Complementary Medicine by Women Enrolled in an HMO Setting (1998) (2)
- Breast Density Knowledge in a Screening Mammography Population Exposed to Density Notification. (2022) (2)
- Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population. (2022) (2)
- Feasibility and acceptability of conducting a randomized clinical trial designed to improve interpretation of screening mammography. (2013) (2)
- Improving the promise of embedded pragmatic trials: Surmountable barriers encountered in an evaluation of home-based HPV self-sampling to increase cervical cancer screening in overdue women (2019) (2)
- Endocrine therapy initiation among women with stage I–III invasive, hormone receptor-positive breast cancer from 2001–2016 (2022) (1)
- Predictors of preoperative MRI for breast cancer: differences by data source. (2015) (1)
- Abstract 589: Circulating progesterone is associated with increased postmenopausal breast cancer risk: B~FIT cohort (2019) (1)
- Imaging Surveillance Options for Individuals With a Personal History of Breast Cancer: AJR Expert Panel Narrative Review. (2022) (1)
- The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems (2022) (1)
- Factors to Consider in Developing Breast Cancer Risk Models to Implement into Clinical Care (2020) (1)
- Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system. (2020) (1)
- Endogenous Progestogens and Colorectal Cancer Risk among Postmenopausal Women (2021) (1)
- Re: Cancer outcomes in DCIS patients without locoregional treatment. (2019) (1)
- Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women (2015) (1)
- Women's Breast Cancer Screening Confidence by Screening Modality and Breast Density: A Breast Cancer Surveillance Consortium Survey Study. (2022) (0)
- Corrigendum to "Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system" [Contemp. Clin. Trials 64 (2018) 77-87]. (2019) (0)
- 67 Breast biopsy patterns and findings among older women undergoing screening mammography: what is the impact of age and comorbidity? (2019) (0)
- Abstract A108: Improving communication and management following a positive home HPV self-sampling kit result (2023) (0)
- Comparative performance of surveillance mammography and breast MRI in women with a history of breast cancer. (2016) (0)
- Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B∼FIT Cohort (2021) (0)
- Breast biopsy patterns and findings among older women undergoing screening mammography: The role of age and comorbidity. (2021) (0)
- Correction to: The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems (2022) (0)
- A Population-Based Randomized Trial to Assess the Effects of Short-Term Cessation of HRT on Mammography Assessments and Breast Density (2005) (0)
- Predictors of Preoperative Magnetic Resonance Imaging for Breast Cancer: Differences by Data Source (2018) (0)
- Will Women in Managed Care Use a Mailed HRT Workbook? The EnPower Study Workbook Trial: P-52. (1999) (0)
- P-33.: Counseling about HRT (1997) (0)
- Helping women achieve long-term continuance of estrogen replacement therapy (ERT) and hormone replacement therapy (HRT) (1999) (0)
- P-32.: Healthcare Provider Characteristics and Encouragement to Use HRT (1997) (0)
- Are breast density and family history associated with pre-operative breast MRI use? (2015) (0)
- Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening (2023) (0)
- Reductions in Medical Resource Use Among Primary Care Physicians Following the Adoption of Personalized, Transparent Reporting (2015) (0)
- Competing Risks for a Diagnosis of Invasive Breast Cancer-Reply. (2019) (0)
- Adverse events after screening and follow-up colonoscopy (2011) (0)
- Abstract P1-08-04: Withdrawn (2019) (0)
- Authors' response: Cost-effectiveness evidence for HPV self-sampling could be improved by giving greater attention to vulnerable populations. (2020) (0)
- Treatment-Related Thoracic Soft Tissue Sarcomas in Two US Cohorts of Breast Cancer Survivors (2022) (0)
- Accuracy of tumor registry versus pharmacy dispensings for breast cancer adjuvant endocrine therapy (2022) (0)
- PS3-16: The Influence of Travel Time on Breast Cancer Diagnosis and Treatment (2010) (0)
- A Population-Based Randomized Trial to Assess the Effects of Short-Term Cessation of Hormone Replacement Therapy on Mammography Assessments and Breast Density (2008) (0)
- Effect of Patient Characteristics on Uptake of Screening Using a Mailed Human Papillomavirus Self-sampling Kit (2022) (0)
- Abstract B86: Estrogen metabolism and postmenopausal breast cancer risk in the B∼FIT cohort (2012) (0)
- Response to Pisano, Gastonis, Sparano, et al. (2021) (0)
- Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density (2022) (0)
- Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort (2023) (0)
- Future Research Suggestions for Multigene Testing in Unselected Populations-Reply. (2020) (0)
- Breast biopsy patterns and findings among older women undergoing screening mammography: what is the impact of age and comorbidity? (2019) (0)
- WHO CAN QUIT? FACTORS ASSOCIATED WITH NON-COMPLIANCE WITH SHORT-TERM HT SUSPENSION PRIOR TO SCREENING MAMMOGRAPHY (2009) (0)
- Iconographies supplémentaires de l'article : Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging (2016) (0)
- Abstract IA23: Opportunities and lessons learned from the Cancer Research Network (2020) (0)
- Tissue sampling frequency and breast pathology diagnoses following mammography: Time trends and age group analysis from the Breast Cancer Surveillance Consortium (BCSC). (2013) (0)
- Qualities of HRT Counseling: Findings from the EnPower Study: P-51. (1999) (0)
- Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension. (2010) (0)
- P-31.: What Factors Account for Differences in HRT Prescribing by Healthcare Providers in a Health Maintenance Organization? The EnPOWER Provider Survey (1997) (0)
- Title Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer : the B ∼ FIT Cohort . Permalink (2019) (0)
- Trends in Estrogen Receptor Testing and Tamoxifen Initiation After Ductal Carcinoma in Situ During 1996–2011 (2015) (0)
- Abstract 2359: Endogenous progestogens and colorectal cancer risk among postmenopausal women (2020) (0)
- Locoregional Treatment of Breast Cancer in Women With and Without Preoperative MRI (2017) (0)
- Choosing Wisely: Using the EHR to Identify Variability in Provider Ordering Behavior for High-End Imaging of the Head (2015) (0)
- Abstract 1603: Estrogen metabolites and colorectal cancer risk in postmenopausal women in the Breast and Bone Follow-up to the Fracture Intervention Trial (B∼FIT) (2014) (0)
- Comorbidity index score increases due to coding artifacts. (2019) (0)
- Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status (2023) (0)
- Statins and Breast Cancer Risk: Is There an Association? (2006) (0)
- Attitudes Scale: The EnPower Study (2016) (0)
- Taking Action on Overuse: Implementing an Action-Planning Framework to Engage Providers (2017) (0)
- Authors' response. (2013) (0)
- Primary Care Provider Perspectives on Reducing Low-Value Care (2015) (0)
- Performance of statistical and machine learning risk prediction models for surveillance benefits and failures in breast cancer survivors. (2023) (0)
- Circulating serum xenoestrogens and mammographic breast density (2013) (0)
- PS2-43: Prostate-Specific Antigen Tests in Clinical Practice over the Past Decade: Is the Threshold for Recommending Biopsy Dropping? (2011) (0)
- PS2-36: Influence of Travel Time on the Receipt of Surveillance Mammograms for Women With History of Breast Cancer (2010) (0)
This paper list is powered by the following services:
Other Resources About Diana Buist
What Schools Are Affiliated With Diana Buist?
Diana Buist is affiliated with the following schools:
